Results 11 to 20 of about 45,456 (232)

Renal aspergillosis after COVID‐19‐associated pulmonary aspergillosis: A case report [PDF]

Clinical Case Reports, 2023
Key Clinical Message Renal aspergillosis is a rare condition and this case the first case of Renal aspergillosis reported after COVID‐19‐associated pulmonary aspergillosis. Renal symptoms should arise clinical suspicion to renal involvement that happened
Roya Ghasemian, Lale Vahedi Larijani, Kimia Rasouli, Mohammad Taghi Hedayati, Chanour Tavakol, Keyvan Heydari, Hamidreza Zalpoor, Aref Hoseini   +7 more
doaj   +2 more sources

Pulmonary aspergillosis [PDF]

Diagnostic and Interventional Imaging, 2015
Aspergillosis is a mycotic disease usually caused by Aspergillus fumigatus, a saprophytic and ubiquitous airborne fungus. Aspergillus-related lung diseases are traditionally classified into four different forms, whose occurrence depends on the immunologic status of the host and the existence of an underlying lung disease.
Chabi, M.L., Goracci, A., Roche, N., Paugam, A., Lupo, A., Revel, M.P.   +5 more
openaire   +4 more sources

Pediatric Pulmonary and Thoracic Aspergillosis [PDF]

Siriraj Medical Journal, 2020
Aspergillus infection can cause significant disease in an immunocompromised host and lungs are the most common site of infection. Various forms of aspergillus involving lung parenchyma have been described including aspergilloma, allergic bronchopulmonary
Preeyacha Pacharn, Punchama Pacharn, Chantima Rongviriyapanich, Thomas Bryce   +3 more
doaj   +1 more source

Current Promising Therapeutic Targets for Aspergillosis Treatment [PDF]

, 2021
Aspergillosis is a fungal disease caused by different species of Aspergillus. They live in soil,dust and decomposed material. Number of Aspergillus species found till now is about 300 and more are still to be identified.
Shweta Srivastava, Ashutosh Mani, Neha Shree Maurya, Shikha Kushwah   +3 more
core   +1 more source

Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis. [PDF]

, 2022
Despite best available therapy, cerebral aspergillosis is an often-lethal complication of disseminated aspergillosis. There is an urgent need to expand the currently limited therapeutic options.
Aregger, Andrea, Zimmerli, Stefan, Ullmann, Irina, Leib, Stephen L., Leib, Stephen L   +4 more
core   +1 more source

Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™ [PDF]

, 2011
Background: Despite advances in the treatment, the morbidity and mortality rate associated with invasive aspergillosis remains unacceptably high (70–90%) in immunocompromised patients.
M N V Ravi Kumar, Sharp Andrew, Jagdishbhai L. Italia, Carter, Katharine C., Carter Katharine C., Kumar, M. N V Ravi, Kumar M. N. V. Ravi, Jagdishbhai L Italia, Italia Jagdishbhai L., Italia, Jagdishbhai L., Katharine C. Carter, M. N. V. Ravi Kumar, Andrew Sharp, Italia, Jagdishbhai L, Kumar, M N V Ravi, Warn, Peter, Warn Peter, Sharp, Andrew, Carter, Katharine C, Katharine C Carter, Peter Warn   +20 more
core   +1 more source

Successful long-term terbinafine therapy in an asthmatic patient with Aspergillus sensitization and bronchiectasis

Medical Mycology Case Reports, 2017
Severe asthma with fungal sensitization (SAFS) is estimated to affect ~25% of patients with poorly controlled asthma. Tri-azole therapy is effective in only 60–80% and side effects are common.
Isabel Rodriguez-Goncer, Rob Niven, David W. Denning   +2 more
doaj   +1 more source

Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. [PDF]

, 2009
Contains fulltext : 81920.pdf (Publisher’s version ) (Open Access)We reported the emergence of resistance to medical triazoles of Aspergillus fumigatus isolates from patients with invasive aspergillosis.
Snelders, Eveline, Melchers, W.J.G., Rijs, Anthonius J. M. M., A. J. M. M. Rijs, Veld, R., G. H. J. Kema, Verweij, P.E., Melchers, Willem J. G., Snelders, E., Kema, G.H.J., W. J. G. Melchers, Kema, G.H., Verweij, Paul E., E. Snelders, Rijs, A., Rijs, A.J.M.M., Huis In 't Veld, Robert A. G., Huis In 't Veld, R.A., P. E. Verweij, Kema, Gert H. J., R. A. G. Huis in 't Veld   +20 more
core   +1 more source

Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study

Frontiers in Cellular and Infection Microbiology, 2022
This study aimed to obtain further in-depth information on the value of metagenomic next-generation sequencing (mNGS) for diagnosing pulmonary aspergillosis in non-neutropenic patients.
Shujun Bao, Huihui Song, Yang Chen, Caiming Zhong, Hao Tang   +4 more
doaj   +1 more source

Nebulised N-Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature

Journal of Fungi, 2018
Many chronic lung diseases are characterized by the hypersecretion of mucus. In these conditions, the administration of mucoactive agents is often indicated as adjuvant therapy. N-acetylcysteine (NAC) is a typical example of a mucolytic agent.
Akaninyene Otu, Philip Langridge, David W. Denning   +2 more
doaj   +1 more source